McCormick Michelle M, Rahimi Farid, Bobryshev Yuri V, Gaus Katharina, Zreiqat Hala, Cai Hong, Lord Reginald S A, Geczy Carolyn L
School of Medical Sciences, St. Vincent's Hospital, University of New South Wales, Sydney, Australia.
J Biol Chem. 2005 Dec 16;280(50):41521-9. doi: 10.1074/jbc.M509442200. Epub 2005 Oct 10.
Atherogenesis is a complex process involving inflammation. S100A8 and S100A9, the Ca2+-binding neutrophil cytosolic proteins, are associated with innate immunity and regulate processes leading to leukocyte adhesion and transmigration. In neutrophils and monocytes the S100A8-S100A9 complex regulates phosphorylation, NADPH-oxidase activity, and fatty acid transport. The proteins have anti-microbial properties, and S100A8 may play a role in oxidant defense in inflammation. Murine S100A8 is regulated by inflammatory mediators and recruits macrophages with a proatherogenic phenotype. S100A9 but not S100A8 was found in macrophages in ApoE-/- murine atherosclerotic lesions, whereas both proteins are expressed in human giant cell arteritis. Here we demonstrate S100A8 and S100A9 protein and mRNA in macrophages, foam cells, and neovessels in human atheroma. Monomeric and complexed forms were detected in plaque extracts. S100A9 was strongly expressed in calcifying areas and the surrounding extracellular matrix. Vascular matrix vesicles contain high levels of Ca2+-binding proteins and phospholipids that regulate calcification. Matrix vesicles characterized by electron microscopy, x-ray microanalysis, nucleoside triphosphate pyrophosphohydrolase assay and cholesterol/phospholipid analysis contained predominantly S100A9. We propose that S100A9 associated with lipid structures in matrix vesicles may influence phospholipid-Ca2+ binding properties to promote dystrophic calcification. S100A8 and S100A9 were more sensitive to hypochlorite oxidation than albumin or low density lipoprotein and immunoaffinity confirmed S100A8-S100A9 complexes; some were resistant to reduction, suggesting that hypochlorite may contribute to protein cross-linking. S100A8 and S100A9 in atherosclerotic plaque and calcifying matrix vesicles may significantly influence redox- and Ca2+-dependent processes during atherogenesis and its chronic complications, particularly dystrophic calcification.
动脉粥样硬化的形成是一个涉及炎症的复杂过程。S100A8和S100A9是与钙离子结合的中性粒细胞胞质蛋白,与先天免疫相关,并调节导致白细胞黏附和迁移的过程。在中性粒细胞和单核细胞中,S100A8 - S100A9复合物调节磷酸化、NADPH氧化酶活性和脂肪酸转运。这些蛋白具有抗菌特性,并且S100A8可能在炎症中的氧化防御中发挥作用。小鼠S100A8受炎症介质调节,并募集具有促动脉粥样硬化表型的巨噬细胞。在载脂蛋白E基因敲除小鼠的动脉粥样硬化病变的巨噬细胞中发现了S100A9而不是S100A8,而在人类巨细胞动脉炎中这两种蛋白均有表达。在此我们证明了人类动脉粥样硬化斑块中的巨噬细胞、泡沫细胞和新生血管中存在S100A8和S100A9蛋白及mRNA。在斑块提取物中检测到了单体和复合形式。S100A9在钙化区域及周围的细胞外基质中强烈表达。血管基质小泡含有高水平的与钙离子结合的蛋白和调节钙化的磷脂。通过电子显微镜、X射线微分析、核苷三磷酸焦磷酸水解酶测定和胆固醇/磷脂分析鉴定的基质小泡主要含有S100A9。我们提出,与基质小泡中的脂质结构相关的S100A9可能会影响磷脂 - 钙离子的结合特性,从而促进营养不良性钙化。与白蛋白或低密度脂蛋白相比,S100A8和S100A9对次氯酸盐氧化更敏感,免疫亲和证实了S100A8 - S100A9复合物;其中一些对还原有抗性,这表明次氯酸盐可能有助于蛋白质交联。动脉粥样硬化斑块和钙化基质小泡中的S100A8和S100A9可能在动脉粥样硬化形成及其慢性并发症(尤其是营养不良性钙化)过程中显著影响氧化还原和钙离子依赖性过程。